September 11, 2023 Thomas BeethamLetter Agreement • March 21st, 2024 • Dianthus Therapeutics, Inc. /DE/ • Pharmaceutical preparations
The purpose of this letter agreement (“Agreement”) is to confirm the terms of your separation of employment from Magenta Therapeutics, Inc. (“Magenta” or the “Company”).1 The Consideration being offered below is contingent on your agreement to and compliance with the provisions of this Agreement. This Agreement shall be effective on the eighth (8th) day after you sign it (the “Effective Date”), at which time it shall become final and binding on all parties.
May 12, 2023 Lisa Olson Dear Lisa: The purpose of this letter agreement (“Agreement”) is to confirm the terms of yourLisa Olson • March 21st, 2024 • Dianthus Therapeutics, Inc. /DE/ • Pharmaceutical preparations
separation of employment from Magenta Therapeutics, Inc. (“Magenta” or the “Company”).1 The Consideration being offered below is contingent on your agreement to and compliance with the provisions of this Agreement. This Agreement shall be effective on the eighth (8th) day after you sign it (the “Effective Date”), at which time it shall become final and binding on all parties.
Amended and Restated DIANTHUS THERAPEUTICS, INC. STOCK OPTION AND INCENTIVE PLAN STOCK OPTION AGREEMENTStock Option Agreement • March 21st, 2024 • Dianthus Therapeutics, Inc. /DE/ • Pharmaceutical preparations • Delaware
Pursuant to the Amended and Restated Dianthus Therapeutics, Inc. Stock Option and Incentive Plan (the “Plan”), Dianthus Therapeutics, Inc. (the “Company”) hereby grants to the Optionee named below an option (the “Stock Option”) to purchase on or prior to the Expiration Date set forth below all or part of the number of shares of Stock set forth below (the “Option Shares”) at the Exercise Price per Share set forth below subject to the terms and conditions set forth herein and in the Plan. Capitalized terms in this Stock Option Agreement (this “Agreement”) shall have the meanings specified in the Plan, unless a different meaning is specified herein.
February 7, 2023 Jason Gardner Dear Jason:Letter Agreement • March 21st, 2024 • Dianthus Therapeutics, Inc. /DE/ • Pharmaceutical preparations
The purpose of this letter agreement (“Agreement”) is to confirm the terms of your separation of employment from Magenta Therapeutics, Inc. (“Magenta” or the “Company”).1 The Consideration being offered below is contingent on your agreement to and compliance with the provisions of this Agreement. This Agreement shall be effective on the eighth (8th) day after you sign it (the “Effective Date”), at which time it shall become final and binding on all parties.
September 11, 2023Dianthus Therapeutics, Inc. /DE/ • March 21st, 2024 • Pharmaceutical preparations
By way of this letter, Section 5 of your Offer Letter dated January 17, 2022 (the “Offer Letter”) by and between you and Dianthus Therapeutics OpCo, Inc. (f/k/a Dianthus Therapeutics, Inc.) (the “Company”) is hereby amended to and restated in its entirety to read as follows:
